IRulya Therapeutics, Inc. (IRLA)
39.00
+5.22
(+15.47%)
USD |
NASDAQ |
Nov 10, 10:07
IRulya Therapeutics Cash and Short Term Investments (Quarterly) : 115.98M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 115.98M |
| March 31, 2026 | 18.16M |
| December 31, 2025 | 17.75M |
| September 30, 2025 | 26.29M |
| June 30, 2025 | 34.71M |
| March 31, 2025 | 31.60M |
| December 31, 2024 | 40.78M |
| September 30, 2024 | 47.85M |
| June 30, 2024 | 59.44M |
| March 31, 2024 | 67.82M |
| December 31, 2023 | 75.06M |
| September 30, 2023 | 83.22M |
| June 30, 2023 | 87.56M |
| March 31, 2023 | 90.20M |
| December 31, 2022 | 90.18M |
| Date | Value |
|---|---|
| September 30, 2022 | 94.34M |
| June 30, 2022 | 94.66M |
| March 31, 2022 | 91.52M |
| December 31, 2021 | 106.80M |
| September 30, 2021 | 114.41M |
| June 30, 2021 | 129.95M |
| March 31, 2021 | 147.04M |
| December 31, 2020 | 133.82M |
| September 30, 2020 | 137.79M |
| June 30, 2020 | 144.50M |
| March 31, 2020 | 162.42M |
| December 31, 2019 | 99.86M |
| September 30, 2019 | 120.72M |
| June 30, 2019 | 128.54M |
| March 31, 2019 | 59.29M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 456.22M |
| PepGen Inc. | 117.24M |
| Q32 Bio, Inc. | 289.59M |
| Bridgebio Oncology Therapeutics, Inc. | 225.71M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |